US 12,274,723 B2
Bacteriophage compositions and methods for treatment of bacterial infections
Anthony Maresso, Houston, TX (US); Robert Ramig, Houston, TX (US); Sabrina Green, Houston, TX (US); Austen Terwilliger, Houston, TX (US); Keiko Salazar, Houston, TX (US); Justin R. Clark, Houston, TX (US); and Barbara Trautner, Houston, TX (US)
Assigned to Baylor College of Medicine, Houston, TX (US); and United States Government as Represented by the Department of Veterans Affairs, Washington, DC (US)
Filed by Baylor College of Medicine, Houston, TX (US); and United States Government as Represented by the Department of Veterans Affairs, Washington, DC (US)
Filed on Jun. 24, 2024, as Appl. No. 18/751,599.
Application 18/751,599 is a continuation of application No. 18/152,077, filed on Jan. 9, 2023, granted, now 12,036,255.
Application 18/152,077 is a continuation of application No. PCT/US2022/080888, filed on Dec. 5, 2022.
Prior Publication US 2024/0335489 A1, Oct. 10, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 35/76 (2015.01); A61P 31/04 (2006.01); C12N 7/00 (2006.01)
CPC A61K 35/76 (2013.01) [A61P 31/04 (2018.01); C12N 7/00 (2013.01); C12N 2795/10132 (2013.01); C12N 2795/10171 (2013.01); C12N 2795/10232 (2013.01); C12N 2795/10271 (2013.01)] 27 Claims
 
1. A composition comprising bacteriophage HP3.2.